无创幽门螺杆菌检测市场研究报告按测试类型（尿素呼气测试、血清学测试、粪便抗原测试）、最终用户（医院、诊断实验室、研究机构）、技术（分子诊断、免疫测定、微生物测试）、病情类型（有症状感染、无症状感染、治疗后评估）和区域（北美、欧洲、南美、亚太地区、中东和非洲) - 2034 年预测
ID: MRFR/HC/32188-HCR | 100 Pages | Author: Rahul Gotadki| July 2025
<
无创幽门螺杆菌检测市场概览 H2
根据 MRFR 分析，非侵入性幽门螺杆菌检测市场规模估计为 2.01（十亿美元） ）在 2022 年。非侵入性幽门螺杆菌检测市场预计将从 2023 年的 2.12（十亿美元）增长到到 2032 年，非侵入性幽门螺杆菌检测市场 CAGR（增长率）预计将达到 3.5（十亿美元）预测期内（2024 - 2032）为 5.71%。<
重点介绍非侵入性幽门螺杆菌检测市场的主要趋势
由于人们对胃健康意识的增强和胃部健康意识的增强，非侵入性幽门螺杆菌检测市场正在出现显着增长。幽门螺杆菌感染的患病率不断上升。早期准确诊断的需求以及患者对非侵入性方法的偏好等因素极大地推动了市场发展势头。快速检测技术的日益普及和诊断技术的进步进一步支持了市场扩张。此外，医疗保健提供者和诊断公司之间的合作正在增强非侵入性检测解决方案的可及性。有待探索的机会包括开发创新的测试方法，提供更高的灵敏度和特异性，使测试变得更容易供医疗保健专业人员识别感染。将远程医疗整合到测试过程中也可以创造增长途径，因为远程咨询可以带来更快的诊断和治疗。此外，扩大发展中地区的市场覆盖范围有助于解决缺乏先进诊断选项的医疗保健系统中未满足的需求。最近的趋势表明转向更复杂的检测试剂盒，利用生物标志物和先进的遗传技术来改善准确度。强调以患者为中心的护理促进了用户友好的测试设备的开发，从而实现了自我测试在家里。人们对预防性医疗保健和生活方式相关举措的兴趣日益浓厚，导致人们更加关注消化健康，进一步推动了对非侵入性检测方案的需求。随着市场的不断发展，利益相关者必须时刻关注新兴技术和患者偏好，以充分利用这些技术成长的机会。来源：一级研究、二级研究、MRFR 数据库和分析师评论 /跨度<
非侵入性幽门螺杆菌检测市场驱动因素 H2
| Report Attribute/Metric | Details |
| Market Size 2024 | 2.37 (USD Billion) |
| Market Size 2025 | 2.51 (USD Billion) |
| Market Size 2034 | 4.14 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.71 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Market Forecast Units | USD billion |
| Key Companies Profiled | Siemens Healthineers, Helicobacter pylori Test, Inc., Roche Diagnostics, Hugo Health, Meridian Bioscience, Abbott Laboratories, Biohit Oyj, Genomic Health, Quest Diagnostics, Thermo Fisher Scientific, Saint-Gobain Performance Plastics, Alere Inc., Becton Dickinson, F. HoffmannLa Roche Ltd, DiaSorin |
| Segments Covered | Test Type, End User, Technology, Condition Type, Regional |
| Key Market Opportunities | Increased prevalence of gastrointestinal disorders, Growing demand for rapid diagnostics, Advancements in testing technologies, Rising awareness of H. pylori infections, Expanding healthcare access in developing regions |
| Key Market Dynamics | Increasing prevalence of H. pylori infections, Growing demand for rapid diagnostics, Advancements in testing technologies, Rise in gastrointestinal disorders, Shift towards non-invasive procedures |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Non-invasive Helicobacter Pylori Testing Market is expected to be valued at 4.14 USD billion by 2034.
The market is expected to grow at a CAGR of 5.71% from 2025 to 2034.
North America is expected to dominate the market with an anticipated value of 1.4 USD billion by 2032.
The Urea Breath Test segment is projected to reach a market value of 1.4 USD billion by 2032.
Key players in the market include Siemens Healthineers, Roche Diagnostics, and Abbott Laboratories, among others.
The Serology Test segment is expected to be valued at 1.1 USD billion by 2032.
The Fecal Antigen Test segment is anticipated to reach a market value of 1.0 USD billion by 2032.
The Asia-Pacific region is projected to reach a market value of 0.7 USD billion by 2032.
The South American market is expected to be valued at 0.25 USD billion by 2032.
Some challenges include regulatory hurdles and the variability in testing technologies and methods.
Comments
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
